Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Comparing bowel cleansing agents Plenvu and Picoprep before colonoscopy

Official title: A Randomised Controlled Trial to Compare Efficacy and Tolerability of Plenvu® and Picoprep® as Cleansing Agents Before Colonoscopy

Run by Aalborg University Hospital · NCT05436054 · Data updated 2026-11-12

This study is testing whether Plenvu or Picoprep works better and is easier to handle for people getting ready for a colonoscopy.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorAalborg University Hospital
Academic / other
Locations1 site (Aalborg, North Jutland)
StatusRecruiting
StartedOctober 1, 2022
Main results expectedDecember 1, 2025
Study endsDecember 1, 2025
Registry record updatedNovember 19, 2024
Trial IDNCT05436054 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old who are scheduled for an ambulatory colonoscopy.

Probably not a fit

Patients with severe heart or renal failure, pregnant or breastfeeding individuals, and those with specific gastrointestinal conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial aims to compare the efficacy and tolerability of two bowel cleansing agents, Plenvu and Picoprep, prior to colonoscopy. A total of 400 patients referred for colonoscopy at a single center in North Jutland will be randomly assigned to receive either Plenvu or Picoprep. Participants will complete a questionnaire regarding expected side effects and their experience with the bowel cleansing agents. The quality of bowel cleansing will be assessed using a blinded scoring system to ensure unbiased evaluation by the colonoscopist.

Why it matters

Potential benefit: If successful, this study could lead to improved bowel preparation methods, enhancing the effectiveness of colonoscopies and potentially increasing the detection rates of colonic lesions.

How similar studies have gone: Previous studies have shown varying success with different bowel cleansing agents, but this specific comparison of Plenvu and Picoprep is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ambulant colonoscopy
* Older than18

Exclusion Criteria:

* Younger than 18
* Known with severe heart failure
* Known with severe renal failure (eGFR\<30)
* Known for colonic stenosis
* Pregnant or breastfeeding
* Acute colonoscopy
* Cancer screening program colonoscopy
* Mentally retarded
* Redo colonoscopy of patients included in this study and colonoscopy was canceled because of bad bowel preparation.
* Patients with Phenylketonuria
* Patients with Glucose-6-phosphate-dehydrogenase deficiency
* Patients with colon or rectum resection

Where it's running

  • Aalborg University hospital
    Aalborg, North Jutland, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.